The Journal of Immunology, Vol 149, Issue 8 2729-2735, Copyright © 1992 by American Association of Immunologists

ARTICLES

Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies

S Pruksakorn, A Galbraith, RA Houghten and MF Good
Molecular Immunology Unit, Queensland Institute of Medical Research, Brisbane, Australia.

To identify conserved T and B cell epitopes on the M protein of group A beta-hemolytic streptococci, overlapping synthetic peptides that span the conserved carboxyl-terminal segment of the M-5 protein were constructed and used to immunize a panel of H-2 congenic mice. Proliferative T cell epitopes were identified and, in many cases, mice immunized with these peptides produced high titer antibodies to the same peptides indicating that these proliferative epitopes could also stimulate Th cells. Peptide-specific T cells and antisera were tested for their reactivity with porcine myosin, tropomyosin, human heart myosin synthetic peptides, and extracts of human pericardial and atrial heart tissue. Although there was minimal response of M peptide-specific T cells to any of these Ag, certain M peptide-specific antisera reacted to immunoblotted porcine myosin and to an immunoblotted extract of human atrial heart tissue. However, two conserved peptides, LRRDLDASREAKKQVEKALE and KLTEKEKAELQAKLEAEAKA, stimulated peptide- specific antibodies in B10.BR and B10.D2 mice respectively, which reacted minimally if at all with human atrial heart tissue extract. Furthermore, antisera to the former peptide, in a bactericidal assay involving human monocytes, could mediate killing of streptococci (82% of bacteria). Although this level of killing is less than that produced by antisera to the highly polymorphic type-specific aminoterminus (up to 100% killing), it provides evidence that conserved epitopes can be the targets of bactericidal antibodies. These conserved epitopes may be useful in a vaccine because they also stimulate T cells, thus allowing development of immunologic memory and natural boosting of an immune response after natural exposure.

This article has been cited by other articles:

				P. Mannam, K. F. Jones, and B. L. Geller Mucosal Vaccine Made from Live, Recombinant Lactococcus lactis Protects Mice against Pharyngeal Infection with Streptococcus pyogenes Infect. Immun., June 1, 2004; 72(6): 3444 - 3450. [Abstract] [Full Text] [PDF]

				K. Schulze, E. Medina, G. S. Chhatwal, and C. A. Guzman Identification of B- and T-Cell Epitopes within the Fibronectin-Binding Domain of the SfbI Protein of Streptococcus pyogenes Infect. Immun., December 1, 2003; 71(12): 7197 - 7201. [Abstract] [Full Text] [PDF]

				H. S. Courtney, D. L. Hasty, and J. B. Dale Serum Opacity Factor (SOF) of Streptococcus pyogenes Evokes Antibodies That Opsonize Homologous and Heterologous SOF-Positive Serotypes of Group A Streptococci Infect. Immun., September 1, 2003; 71(9): 5097 - 5103. [Abstract] [Full Text] [PDF]

				C. Olive, M. Batzloff, A. Horvath, T. Clair, P. Yarwood, I. Toth, and M. F. Good Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens Infect. Immun., May 1, 2003; 71(5): 2373 - 2383. [Abstract] [Full Text] [PDF]

				C. Olive, M. R. Batzloff, A. Horvath, A. Wong, T. Clair, P. Yarwood, I. Toth, and M. F. Good A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies Infect. Immun., May 1, 2002; 70(5): 2734 - 2738. [Abstract] [Full Text] [PDF]

				E. R. Brandt, P. J. Yarwood, D. J. McMillan, H. Vohra, B. Currie, L. Mammo, S. Pruksakorn, J. Saour, and M. F. Good Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations Int. Immunol., October 1, 2001; 13(10): 1335 - 1343. [Abstract] [Full Text] [PDF]

				E. R. Brandt, T. Teh, W. A. Relf, R. I. Hobb, and M. F. Good Protective and Nonprotective Epitopes from Amino Termini of M Proteins from Australian Aboriginal Isolates and Reference Strains of Group A Streptococci Infect. Immun., December 1, 2000; 68(12): 6587 - 6594. [Abstract] [Full Text] [PDF]

				M. W. Cunningham Pathogenesis of Group A Streptococcal Infections Clin. Microbiol. Rev., July 1, 2000; 13(3): 470 - 511. [Abstract] [Full Text] [PDF]

				S. Pruksakorn, N. Sittisombut, C. Phornphutkul, C. Pruksachatkunakorn, M. F. Good, and E. Brandt Epidemiological Analysis of Non-M-Typeable Group A Streptococcus Isolates from a Thai Population in Northern Thailand J. Clin. Microbiol., March 1, 2000; 38(3): 1250 - 1254. [Abstract] [Full Text]

				C. Hirunpetcharat, P. Vukovic, X. Q. Liu, D. C. Kaslow, L. H. Miller, and M. F. Good Absolute Requirement for an Active Immune Response Involving B Cells and Th Cells in Immunity to Plasmodium yoelii Passively Acquired with Antibodies to the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein-1 J. Immunol., June 15, 1999; 162(12): 7309 - 7314. [Abstract] [Full Text] [PDF]

				E. R. Brandt, W. A. Hayman, B. Currie, J. Carapetis, D. C. Jackson, K.-A. Do, and M. F. Good Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities Int. Immunol., April 1, 1999; 11(4): 569 - 576. [Abstract] [Full Text] [PDF]

				L. Miller, M. Good, and G Milon Malaria pathogenesis Science, June 24, 1994; 264(5167): 1878 - 1883. [Abstract] [PDF]